We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current AKYA market cap is 157.9M. The company's latest EPS is USD -1.2793 and P/E is -2.49.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 21.41M | 23.52M | 25.22M | 26.49M | 18.35M |
| Operating Income | -17.21M | -18.71M | -12.31M | -9.44M | -18.44M |
| Net Income | -18.8M | -20.8M | -12.92M | -10.8M | -23.48M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 43.44M | 42.44M | 54.92M | 74.96M | 96.63M |
| Operating Income | -12.3M | -12.01M | -39.3M | -66.11M | -57.67M |
| Net Income | -14.75M | -16.71M | -44.37M | -70.64M | -63.32M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 154.3M | 188.88M | 177.24M | 180.37M | 154.75M |
| Total Liabilities | 112.17M | 116.98M | 115.27M | 126.6M | 122.03M |
| Total Equity | 42.12M | 71.9M | 61.97M | 53.77M | 32.72M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 89.41M | 77.66M | 190.91M | 176.03M | 180.37M |
| Total Liabilities | 55.23M | 59.58M | 69.56M | 117.45M | 126.6M |
| Total Equity | -30.16M | -51.03M | 121.35M | 58.58M | 53.77M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.76M | -31.56M | -45.32M | -50.9M | -20.82M |
| Investing | 6.2M | 4.77M | 3.94M | 3.35M | -48.82M |
| Financing | -419k | 45.91M | 45.77M | 56.84M | -444k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.78M | -6.84M | -36.07M | -53.5M | -50.9M |
| Investing | -12.89M | 6.73M | -5.09M | -14.08M | 3.35M |
| Financing | 28.56M | 5.49M | 137.04M | 28.73M | 56.84M |
| Market Cap | 157.9M |
| Price to Earnings Ratio | -2.49 |
| Price to Sales Ratio | 1.63 |
| Price to Cash Ratio | 1.9 |
| Price to Book Ratio | 2.94 |
| Dividend Yield | - |
| Shares Outstanding | 49.5M |
| Average Volume (1 week) | 145.71k |
| Average Volume (1 Month) | 103.87k |
| 52 Week Change | -20.25% |
| 52 Week High | 6.31 |
| 52 Week Low | 1.88 |
| Spread (Intraday) | 1.23 (35.34%) |
| Company Name | Akoya BioSciences Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.akoyabio.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
